Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea
August 23, 2024 – The U.S. Food and Drug Administration (FDA) has announced the approval of Pavblu (aflibercept-ayyh) 2 mg injection (single-dose...
Everything You Need to Know About Breast Density, From the Experts
As a new federal regulation that requires mammography centers to tell their patients how dense their breasts are takes effect, experts explain what breast...
6.7 Percent of U.S. Adults Cannot Use Automatic BP Devices Due to Arm Size
An estimated 6.7 percent of U.S. adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published...
Prenatal Fish Intake Tied to Lower Risk for Autism in Offspring
Prenatal fish intake, but not omega-3 (ω-3) supplement use, may be associated with a lower likelihood of both autism diagnosis and related traits, according...
Outdoor Nighttime Light Exposure Linked to Prevalence of Alzheimer Disease
Exposure to outdoor nighttime light is associated with the prevalence of Alzheimer disease (AD), especially among those aged younger than 65 years, according...
Socioeconomic Disparities Impact Immunotherapy Use in Urologic Cancers
Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell...
First Doses of Mpox Vaccine Reach Africa, But Many More Are Needed
As mpox continues to spread in Africa, Congolese authorities said Thursday that the first batch of vaccines have arrived in that country's capital. The...
Brain's Wiring May Trigger Depression in Some People
A distinct brain pattern appears to make some people more likely to develop depression, a new study indicates. “Deep” functional MRI brain...
Gun Deaths to Children and Teens Have Risen in Almost All States
As news of yet another senseless school shooting makes headlines, a new report finds the number of children who lose their lives to injury and gun violence...
First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA in mIDH1 AML
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2024. Rigel Pharmaceuticals, a commercial stage biotechnology company focused on hematologic disorders and cancer,...
First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
NEW YORK, Sept. 4, 2024. Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic...
3-in-1 Blood Pressure Pill Could Be Treatment Advance
An experimental three-in-one blood pressure pill works better than layering on meds one at a time, a new clinical trial shows. After a month on the combo...
KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema
(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S. Food and Drug Administration (FDA) has accepted...
Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company”...
Recently Added
Recently added consumer and prescribing information: Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive, Ohtuvayre, Sofdra
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Pavblu Pavblu (aflibercept-ayyh) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
- Lazcluze Lazcluze (lazertinib) is a kinase inhibitor used in combination with amivantamab for the treatment of certain patients with epidermal...
- Niktimvo Niktimvo (axatilimab-csfr) is a colony stimulating factor-1 receptor (CSF-1R)-blocking antibody used for the treatment of chronic...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...